Epithelial and Mesenchymal Cell Biology Leukocytes Induce Epithelial to Mesenchymal Transition after Unilateral Ureteral Obstruction in Neonatal Mice

Urinary tract obstruction during renal development leads to tubular apoptosis, tubular atrophy, and interstitial fibrosis. Epithelial to mesenchymal transition (EMT) has been proposed as a key mechanism of myofibroblast accumulation in renal fibrosis. We studied the interplay of leukocyte infiltration, tubular apoptosis, and EMT in renal fibrosis induced by unilateral ureteral obstruction (UUO) in neonatal mice. We show that leukocytes mediate tubular apoptosis and EMT in the developing kidney with obstructive nephropathy. Blocking leukocyte recruitment by using the chemokine receptor-1 antagonist BX471 protected against tubular apoptosis and interstitial fibrosis, as evidenced by reduced monocyte influx, a decrease in EMT, and attenuated collagen deposition. EMT was rapidly induced within 24 hours after UUO along with up-regulation of the transcription factors Snail1 and Snail2/Slug, preceding the induction of -smooth muscle actin and vimentin. In the presence of BX471, the expression of chemokines, as well as of Snail1 and Snail2/Slug, in the obstructed kidney was completely attenuated. This was associated with reduced macrophage and T-cell infiltration, tubular apoptosis, and interstitial fibrosis in the developing kidney. Our findings provide evidence that leukocytes induce EMT and renal fibrosis after UUO and suggest that chemokine receptor-1 antagonism may prove beneficial in obstructive nephropathy. (Am J Pathol 2007, 171:861–871; DOI: 10.2353/ajpath.2007.061199) Congenital obstructive nephropathy is a frequent cause of kidney failure in infants and children. Chronic unilateral ureteral obstruction (UUO) leads to interstitial inflammation, tubular apoptosis, and interstitial fibrosis. Central to these events is the influx of macrophages and lymphocytes into the tubulointerstitium. Macrophages release proinflammatory cytokines, cytotoxic substances, and induce apoptosis in tubular cells. Furthermore, macrophages are critical in promoting extracellular matrix production and fibroblast proliferation. Recently, it has been shown that fibroblasts at sites of inflammation originate either from the bone marrow or from an epithelial to mesenchymal transition (EMT) of tubular cells at sites of injury. This process of EMT is characterized by the loss of epithelial adhesion, polarity, and epithelial cell-specific markers such as E-cadherin. In addition, cells undergoing EMT gain the expression of fibroblast (vimentin) and smooth muscle [ -smooth muscle actin ( -SMA)] markers. These changes lead to an intermediate mesenchymal phenotype, termed the myofibroblast, which is motile and invasive and produces extracellular matrix. Molecular markers for EMT include loss of E-cadherin, increased expression of vimentin and SMA, nuclear localization of activated -catenin, and increased production of the transcription factors Snail1 and Snail2/Slug. Snail1 acts as a key regulator of EMT by suppressing Ecadherin transcription, increasing matrix metalloproteinases, and modulating tight junction protein expression. Snail2/Slug inhibits E-cadherin production, thereby facilitating detachment of epithelial cells, thus enabling them to migrate. Both Snail1 and Snail2 are crucial in the initiation and progression of EMT. Growth factors including transforming growth factor1 (TGF1), fibroblast growth factor-2, and epidermal growth factor have been found to induce EMT. TGF1 stimulates extracellular matrix

[1]  T. Kipari,et al.  Nitric oxide is an important mediator of renal tubular epithelial cell death in vitro and in murine experimental hydronephrosis. , 2006, The American journal of pathology.

[2]  D. Brazil,et al.  Recapitulation of Embryological Programmes in Renal Fibrosis – The Importance of Epithelial Cell Plasticity and Developmental Genes , 2006, Nephron Physiology.

[3]  Chieh-Yu Lin,et al.  Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction , 2006, FEBS letters.

[4]  K. Kitagawa,et al.  Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury. , 2006, Kidney international.

[5]  J. Fitzpatrick,et al.  TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. , 2006, American journal of physiology. Renal physiology.

[6]  E. Hay,et al.  Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. , 2006, Molecular biology of the cell.

[7]  Raghu Kalluri,et al.  The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.

[8]  J. Duffield,et al.  Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. , 2005, The American journal of pathology.

[9]  L. Orci,et al.  Inducible expression of Snail selectively increases paracellular ion permeability and differentially modulates tight junction proteins. , 2005, American journal of physiology. Cell physiology.

[10]  Hua Tang,et al.  Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. , 2005, Blood.

[11]  Jean-Loup Bascands,et al.  Obstructive nephropathy: insights from genetically engineered animals. , 2005, Kidney international.

[12]  R. Horuk,et al.  BX471: a CCR1 antagonist with anti-inflammatory activity in man. , 2005, Mini reviews in medicinal chemistry.

[13]  P. Cockwell,et al.  Macrophages and progressive tubulointerstitial disease. , 2005, Kidney international.

[14]  H. Anders,et al.  Chemokine Receptor CCR1: A New Target for Progressive Kidney Disease , 2005, American Journal of Nephrology.

[15]  M. Nieto,et al.  The Snail genes as inducers of cell movement and survival: implications in development and cancer , 2005, Development.

[16]  R. Mason,et al.  RhoGTPase activation is a key step in renal epithelial mesenchymal transdifferentiation. , 2005, Journal of the American Society of Nephrology : JASN.

[17]  I. Shiraishi,et al.  Adoptive transfer of macrophages ameliorates renal fibrosis in mice. , 2005, Biochemical and biophysical research communications.

[18]  Jiun Wang,et al.  CpG-Independent Synergistic Induction of β-Chemokines and a Dendritic Cell Phenotype by Orthophosphorothioate Oligodeoxynucleotides and Granulocyte-Macrophage Colony-Stimulating Factor in Elutriated Human Primary Monocytes1 , 2005, The Journal of Immunology.

[19]  M. Kretzler,et al.  Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease. , 2005, Journal of the American Society of Nephrology : JASN.

[20]  E. Neilson Setting a trap for tissue fibrosis , 2005, Nature Medicine.

[21]  Wook Kim,et al.  Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor-beta1 expression in acute ureteral obstruction. , 2005, Kidney international.

[22]  H. Lan,et al.  Transforming growth factor‐β and Smad signalling in kidney diseases , 2005, Nephrology.

[23]  S. Forbes,et al.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.

[24]  M. Kretzler,et al.  CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. , 2004, Kidney international.

[25]  R. Atkins,et al.  Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  Thomas Gridley,et al.  The Developmental Transcription Factor Slug Is Widely Expressed in Tissues of Adult Mice , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[27]  M. Miyasaka,et al.  Lymphocyte trafficking across high endothelial venules: dogmas and enigmas , 2004, Nature Reviews Immunology.

[28]  R. Chevalier Perinatal obstructive nephropathy. , 2004, Seminars in perinatology.

[29]  R. Kalluri,et al.  The role of epithelial-to-mesenchymal transition in renal fibrosis , 2004, Journal of Molecular Medicine.

[30]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[31]  R. Fine,et al.  Chronic renal insufficiency in children: The 2001 Annual Report of the NAPRTCS , 2003, Pediatric Nephrology.

[32]  R. Chevalier,et al.  Congenital urinary tract obstruction: Proceedings of the State-Of-The-Art Strategic Planning Workshop—National Institutes of Health, Bethesda, Maryland, USA, 11–12 March 2002 , 2003, Pediatric Nephrology.

[33]  S. Fulda,et al.  Macrophages induce apoptosis in proximal tubule cells , 2003, Pediatric Nephrology.

[34]  V. Kelley,et al.  Reduced Macrophage Recruitment, Proliferation, and Activation in Colony-Stimulating Factor-1-Deficient Mice Results in Decreased Tubular Apoptosis During Renal Inflammation 1 , 2003, The Journal of Immunology.

[35]  S. Kiley,et al.  Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. , 2003, Kidney international.

[36]  S. Klahr,et al.  Obstructive nephropathy and renal fibrosis. , 2002, American journal of physiology. Renal physiology.

[37]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[38]  B. Thornhill,et al.  Recovery from release of ureteral obstruction in the rat: relationship to nephrogenesis. , 2002, Kidney international.

[39]  B. Thornhill,et al.  Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice. , 2002, Kidney international.

[40]  C. Cohen,et al.  A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. , 2002, The Journal of clinical investigation.

[41]  C. Mackay,et al.  Chemokines: immunology's high impact factors , 2001, Nature Immunology.

[42]  D. Taub,et al.  Identification and Characterization of a Potent, Selective, and Orally Active Antagonist of the CC Chemokine Receptor-1* , 2000, The Journal of Biological Chemistry.

[43]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[44]  D. Taub,et al.  Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. , 1996, Journal of immunology.

[45]  J. Fitzpatrick,et al.  Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. , 2006, American journal of physiology. Renal physiology.

[46]  F. Schaefer,et al.  Distinct roles of Mac-1 and its counter-receptors in neonatal obstructive nephropathy. , 2006, Kidney international.

[47]  H. Anders,et al.  Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. , 2006, Kidney international.

[48]  佐藤 三佐子 Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction , 2005 .

[49]  R. Mason,et al.  Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. , 2004, Journal of the American Society of Nephrology : JASN.

[50]  Youhua Liu Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. , 2004, Journal of the American Society of Nephrology : JASN.

[51]  D. Chopin,et al.  Epithelial Cell Plasticity in Development and Tumor Progression , 2004, Cancer and Metastasis Reviews.

[52]  J. Duffield The inflammatory macrophage: a story of Jekyll and Hyde. , 2003, Clinical science.

[53]  S. Segerer,et al.  Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. , 2000, Journal of the American Society of Nephrology : JASN.

[54]  H. S. Kim,et al.  Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. , 1999, The Journal of clinical investigation.